|
|
| (45 intermediate revisions by 17 users not shown) |
| label / nl | label / nl |
| | | Modes of resistance to anti-angiogenic therapy |
| label / ast | label / ast |
| | | Modes of resistance to anti-angiogenic therapy |
| description / sk | description / sk |
| | | vedecký článok (publikovaný 2008-08) |
| description / sr | description / sr |
| | | научни чланак (објављен 2008-08) |
| description / pt | description / pt |
| | | artigo científico (publicado na 2008-08) |
| description / hy | description / hy |
| | | 2008 թվականի օգոստոսին հրատարակված գիտական հոդված |
| description / de | description / de |
| | | wissenschaftlicher Artikel (veröffentlicht in August 2008) |
| description / ar | description / ar |
| | | مقالة علمية (نشرت في أغسطس 2008) |
| description / ko | description / ko |
| | | 2008년 논문 |
| description / tg-cyrl | description / tg-cyrl |
| | | мақолаи илмӣ |
| description / ca | description / ca |
| | | article científic |
| description / bg | description / bg |
| | | научна статия |
| description / es | description / es |
| | | artículo científico publicado en 2008 |
| description / lt | description / lt |
| | | mokslinis straipsnis |
| description / vi | description / vi |
| | | bài báo khoa học |
| description / ru | description / ru |
| | | научная статья |
| description / ast | description / ast |
| | | artículu científicu espublizáu en 2008 |
| description / ka | description / ka |
| | | სამეცნიერო სტატია |
| description / zh-my | description / zh-my |
| | | 2008年论文 |
| description / sq | description / sq |
| | | artikull shkencor |
| description / sr-ec | description / sr-ec |
| | | научни чланак |
| description / he | description / he |
| | | מאמר מדעי |
| description / tg | description / tg |
| | | мақолаи илмӣ |
| description / nan | description / nan |
| | | 2008 nî lūn-bûn |
| description / sv | description / sv |
| | | vetenskaplig artikel |
| description / zh-hant | description / zh-hant |
| | | 2008年論文 |
| description / sr-el | description / sr-el |
| | | naučni članak |
| description / eo | description / eo |
| | | scienca artikolo |
| description / yue | description / yue |
| | | 2008年論文 |
| description / zh-hans | description / zh-hans |
| | | 2008年论文 |
| description / nn | description / nn |
| | | vitskapeleg artikkel |
| description / pt-br | description / pt-br |
| | | artigo científico (publicado na 2008) |
| description / hu | description / hu |
| | | tudományos cikk |
| description / zh-hk | description / zh-hk |
| | | 2008年論文 |
| description / et | description / et |
| | | teaduslik artikkel |
| description / zh-tw | description / zh-tw |
| | | 2008年論文 |
| description / oc | description / oc |
| | | article scientific |
| description / el | description / el |
| | | επιστημονικό άρθρο |
| description / tr | description / tr |
| | | bilimsel makale |
| description / zh-cn | description / zh-cn |
| | | 2008年论文 |
| description / nb | description / nb |
| | | vitenskapelig artikkel |
| description / zh-mo | description / zh-mo |
| | | 2008年論文 |
| description / gl | description / gl |
| | | artigo científico |
| description / pl | description / pl |
| | | artykuł naukowy |
| description / th | description / th |
| | | บทความทางวิทยาศาสตร์ |
| description / tl | description / tl |
| | | artikulong pang-agham |
| description / ro | description / ro |
| | | articol științific |
| description / zh-sg | description / zh-sg |
| | | 2008年论文 |
| description / uk | description / uk |
| | | наукова стаття, опублікована в серпні 2008 |
| description / zh | description / zh |
| | | 2008年论文 |
| description / ja | description / ja |
| | | 2008年の論文 |
| description / wuu | description / wuu |
| | | 2008年论文 |
| description / fi | description / fi |
| | | tieteellinen artikkeli |
| description / hyw | description / hyw |
| | | 2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած |
| description / bn | description / bn |
| | | ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ |
| description / fa | description / fa |
| | | مقالهٔ علمی |
| description / ur | description / ur |
| | | سائنسی مضمون |
| Property / PubMed publication ID: 18650835 / reference |
| | | |
| Property / PMC publication ID: 2874834 / reference |
| | | |
| Property / DOI | |
| | |
| Property / DOI: 10.1038/nrc2442 / rank | |
| Normal rank
| |
| Property / original language of film or TV show | |
| | |
| Property / original language of film or TV show: English / rank | |
| Normal rank
| |
| Property / author name string | |
| Gabriele Bergers
| |
| Property / author name string: Gabriele Bergers / rank | |
| Normal rank
| |
| Property / author name string: Gabriele Bergers / qualifier | |
| | |
| Property / cites work: VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche / reference |
| | | |
| Property / cites work: VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche / reference | |
| | |
| Property / cites work: The role of pericytes in blood-vessel formation and maintenance / reference |
| | | |
| Property / cites work: The role of pericytes in blood-vessel formation and maintenance / reference | |
| | |
| Property / cites work: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors / reference |
| | | |
| Property / cites work: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors / reference | |
| | |
| Property / cites work: Genetic alterations in pancreatic carcinoma / reference |
| | | |
| Property / cites work: Genetic alterations in pancreatic carcinoma / reference | |
| | |
| Property / cites work: The Hallmarks of Cancer / reference |
| | | |
| Property / cites work: The Hallmarks of Cancer / reference | |
| | |
| Property / cites work: Targeting HIF-1 for cancer therapy / reference |
| | | |
| Property / OpenCitations bibliographic resource ID: 604359 / reference |
| | | |
| Property / OpenCitations bibliographic resource ID: 604359 / reference | |
| | |
| Property / instance of |
| | | |
| Property / instance of: review article / rank |
| | | Normal rank |
| Property / instance of: review article / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A quantitative analysis of kinase inhibitor selectivity / rank |
| | | Normal rank |
| Property / cites work: A quantitative analysis of kinase inhibitor selectivity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion / rank |
| | | Normal rank |
| Property / cites work: Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Isolation of putative progenitor endothelial cells for angiogenesis / rank |
| | | Normal rank |
| Property / cites work: Isolation of putative progenitor endothelial cells for angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting / rank |
| | | Normal rank |
| Property / cites work: Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy / rank |
| | | Normal rank |
| Property / cites work: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis / rank |
| | | Normal rank |
| Property / cites work: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The role of myeloid cells in the promotion of tumour angiogenesis / rank |
| | | Normal rank |
| Property / cites work: The role of myeloid cells in the promotion of tumour angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer / rank |
| | | Normal rank |
| Property / cites work: Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Angiogenesis: an organizing principle for drug discovery? / rank |
| | | Normal rank |
| Property / cites work: Angiogenesis: an organizing principle for drug discovery? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Angiogenesis in life, disease and medicine / rank |
| | | Normal rank |
| Property / cites work: Angiogenesis in life, disease and medicine / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors / rank |
| | | Normal rank |
| Property / cites work: Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 / rank |
| | | Normal rank |
| Property / cites work: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumour-educated macrophages promote tumour progression and metastasis / rank |
| | | Normal rank |
| Property / cites work: Tumour-educated macrophages promote tumour progression and metastasis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: VEGF-targeted therapy: mechanisms of anti-tumour activity. / rank |
| | | Normal rank |
| Property / cites work: VEGF-targeted therapy: mechanisms of anti-tumour activity. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The semaphorins: versatile regulators of tumour progression and tumour angiogenesis / rank |
| | | Normal rank |
| Property / cites work: The semaphorins: versatile regulators of tumour progression and tumour angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations? / rank |
| | | Normal rank |
| Property / cites work: Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response / rank |
| | | Normal rank |
| Property / cites work: Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Integrins in angiogenesis and lymphangiogenesis / rank |
| | | Normal rank |
| Property / cites work: Integrins in angiogenesis and lymphangiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab. / rank |
| | | Normal rank |
| Property / cites work: The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion / rank |
| | | Normal rank |
| Property / cites work: HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence / rank |
| | | Normal rank |
| Property / cites work: Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Monoclonal antibodies against components of the IGF system for cancer treatment / rank |
| | | Normal rank |
| Property / cites work: Monoclonal antibodies against components of the IGF system for cancer treatment / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan / rank |
| | | Normal rank |
| Property / cites work: Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Delta-like 4/Notch signaling and its therapeutic implications / rank |
| | | Normal rank |
| Property / cites work: Delta-like 4/Notch signaling and its therapeutic implications / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Bv8 regulates myeloid-cell-dependent tumour angiogenesis / rank |
| | | Normal rank |
| Property / cites work: Bv8 regulates myeloid-cell-dependent tumour angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents / rank |
| | | Normal rank |
| Property / cites work: Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy / rank |
| | | Normal rank |
| Property / cites work: Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Molecular and cellular biomarkers for angiogenesis in clinical oncology / rank |
| | | Normal rank |
| Property / cites work: Molecular and cellular biomarkers for angiogenesis in clinical oncology / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. / rank |
| | | Normal rank |
| Property / cites work: Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Mechanisms of adverse effects of anti-VEGF therapy for cancer / rank |
| | | Normal rank |
| Property / cites work: Mechanisms of adverse effects of anti-VEGF therapy for cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. / rank |
| | | Normal rank |
| Property / cites work: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The multifaceted circulating endothelial cell in cancer: towards marker and target identification. / rank |
| | | Normal rank |
| Property / cites work: The multifaceted circulating endothelial cell in cancer: towards marker and target identification. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration / rank |
| | | Normal rank |
| Property / cites work: Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Rapid vascular regrowth in tumors after reversal of VEGF inhibition / rank |
| | | Normal rank |
| Property / cites work: Rapid vascular regrowth in tumors after reversal of VEGF inhibition / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. / rank |
| | | Normal rank |
| Property / cites work: Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases / rank |
| | | Normal rank |
| Property / cites work: Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression / rank |
| | | Normal rank |
| Property / cites work: Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The HIF pathway in cancer / rank |
| | | Normal rank |
| Property / cites work: The HIF pathway in cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. / rank |
| | | Normal rank |
| Property / cites work: Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival / rank |
| | | Normal rank |
| Property / cites work: PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy / rank |
| | | Normal rank |
| Property / cites work: Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antiangiogenic therapy for cancer: current and emerging concepts / rank |
| | | Normal rank |
| Property / cites work: Antiangiogenic therapy for cancer: current and emerging concepts / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. / rank |
| | | Normal rank |
| Property / cites work: Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway / rank |
| | | Normal rank |
| Property / cites work: Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Genetic and hypoxic regulation of angiogenesis in gliomas / rank |
| | | Normal rank |
| Property / cites work: Genetic and hypoxic regulation of angiogenesis in gliomas / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Cellular abnormalities of blood vessels as targets in cancer / rank |
| | | Normal rank |
| Property / cites work: Cellular abnormalities of blood vessels as targets in cancer / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Can tumor angiogenesis be inhibited without resistance? / rank |
| | | Normal rank |
| Property / cites work: Can tumor angiogenesis be inhibited without resistance? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. / rank |
| | | Normal rank |
| Property / cites work: Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. / rank |
| | | Normal rank |
| Property / cites work: Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy. / rank |
| | | Normal rank |
| Property / cites work: Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: What brings pericytes to tumor vessels? / rank |
| | | Normal rank |
| Property / cites work: What brings pericytes to tumor vessels? / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: HIF-1 as a target for drug development / rank |
| | | Normal rank |
| Property / cites work: HIF-1 as a target for drug development / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The genetics of pancreatic cancer. / rank |
| | | Normal rank |
| Property / cites work: The genetics of pancreatic cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Endothelial-pericyte interactions in angiogenesis. / rank |
| | | Normal rank |
| Property / cites work: Endothelial-pericyte interactions in angiogenesis. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment / rank |
| | | Normal rank |
| Property / cites work: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia / rank |
| | | Normal rank |
| Property / cites work: Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. / rank |
| | | Normal rank |
| Property / cites work: Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pericytes: cell biology and pathology / rank |
| | | Normal rank |
| Property / cites work: Pericytes: cell biology and pathology / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Heterogeneous vascular dependence of tumor cell populations / rank |
| | | Normal rank |
| Property / cites work: Heterogeneous vascular dependence of tumor cell populations / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption / rank |
| | | Normal rank |
| Property / cites work: Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells / rank |
| | | Normal rank |
| Property / cites work: Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents / rank |
| | | Normal rank |
| Property / cites work: Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Control of angiogenesis by the pericyte: molecular mechanisms and significance. / rank |
| | | Normal rank |
| Property / cites work: Control of angiogenesis by the pericyte: molecular mechanisms and significance. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis / rank |
| | | Normal rank |
| Property / cites work: The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pericytes limit tumor cell metastasis / rank |
| | | Normal rank |
| Property / cites work: Pericytes limit tumor cell metastasis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. / rank |
| | | Normal rank |
| Property / cites work: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p / rank |
| | | Normal rank |
| Property / cites work: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival / rank |
| | | Normal rank |
| Property / cites work: Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors / rank |
| | | Normal rank |
| Property / cites work: A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. / rank |
| | | Normal rank |
| Property / cites work: Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A microenvironmental model of carcinogenesis. / rank |
| | | Normal rank |
| Property / cites work: A microenvironmental model of carcinogenesis. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes / rank |
| | | Normal rank |
| Property / cites work: Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. / rank |
| | | Normal rank |
| Property / cites work: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. / rank |
| | | Normal rank |
| Property / cites work: Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pegaptanib for neovascular age-related macular degeneration / rank |
| | | Normal rank |
| Property / cites work: Pegaptanib for neovascular age-related macular degeneration / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. / rank |
| | | Normal rank |
| Property / cites work: A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Tumor-associated endothelial cells with cytogenetic abnormalities. / rank |
| | | Normal rank |
| Property / cites work: Tumor-associated endothelial cells with cytogenetic abnormalities. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms / rank |
| | | Normal rank |
| Property / cites work: Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival / rank |
| | | Normal rank |
| Property / cites work: Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The hypoxic response of tumors is dependent on their microenvironment. / rank |
| | | Normal rank |
| Property / cites work: The hypoxic response of tumors is dependent on their microenvironment. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Effect of p53 status on tumor response to antiangiogenic therapy. / rank |
| | | Normal rank |
| Property / cites work: Effect of p53 status on tumor response to antiangiogenic therapy. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. / rank |
| | | Normal rank |
| Property / cites work: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Pegaptanib sodium for the treatment of age-related macular degeneration / rank |
| | | Normal rank |
| Property / cites work: Pegaptanib sodium for the treatment of age-related macular degeneration / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth / rank |
| | | Normal rank |
| Property / cites work: The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study / rank |
| | | Normal rank |
| Property / cites work: Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Antiangiogenic therapy for cancer: an update / rank |
| | | Normal rank |
| Property / cites work: Antiangiogenic therapy for cancer: an update / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A cancer therapy resistant to resistance / rank |
| | | Normal rank |
| Property / cites work: A cancer therapy resistant to resistance / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed / rank |
| | | Normal rank |
| Property / cites work: Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation / rank |
| | | Normal rank |
| Property / cites work: Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis / rank |
| | | Normal rank |
| Property / cites work: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells / rank |
| | | Normal rank |
| Property / cites work: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells / rank |
| | | Normal rank |
| Property / cites work: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells / reference |
| | | |
| Property / DOI |
| | | |
| Property / DOI: 10.1038/NRC2442 / rank |
| | | Normal rank |
| Property / DOI: 10.1038/NRC2442 / reference |
| | | |
| Property / language of work or name |
| | | |
| Property / language of work or name: English / rank |
| | | Normal rank |
| Property / ResearchGate publication ID |
| | | |
| Property / ResearchGate publication ID: 51424400 / rank |
| | | Normal rank |
| Property / Dimensions Publication ID |
| | | |
| Property / Dimensions Publication ID: 1013847179 / rank |
| | | Normal rank |
| Property / main subject |
| | | |
| Property / main subject: angiogenesis inhibitor / rank |
| | | Normal rank |
| Property / main subject: angiogenesis inhibitor / reference |
| | | |
| Property / author |
| | | |
| Property / author: Gabriele Bergers / rank |
| | | Normal rank |
| Property / author: Gabriele Bergers / qualifier |
| | | |
| Property / author: Gabriele Bergers / qualifier |
| | | |
